Hans Preusting

Co-Founder • DegenRx B.V

Hans Preusting has over 30 years of experience in the Life Science sector and previously served as Chief Business Officer and interim COO of uniQure. He is co-founder of two biotech start-up companies. One of them is DegenRx B.V., which was built based on his gene therapy experience at his time at uniQure. He holds two patents and has published over 20 scientific articles. His expertise is focused on business development, product development and manufacturing. He earned a PhD in biochemistry from the University of Groningen and an MBA from Rotterdam School of Management, The Netherlands. 

Also speaking

Jennifer Rabin

Specialist Leader, Next Gen Therapy Practice • Deloitte

Miguel Forte

Chief Executive Officer, Kiji Therapeutics, President-Elect • ISCT

Simon Hort

Team Leader Adaptive Production Control • Fraunhofer

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.